KA Imaging, based in Waterloo, Ontario, designs and develops X-ray and micro- CT imaging products for medical and veterinary industries. The company is taking cutting-edge research out of Canadian universities, and elsewhere, and converting it into products that will meet the needs of these sectors.
 

The company’s product called “Reveal” offers X-ray technology that allows users to differentiate between soft tissue and bone in patients. This enables us to better understand diseases such as lung cancer, pneumonia and even coronavirus.
 

Using KA Imaging’s patented technology, the detector provides advanced bone and tissue differentiation in the diagnostic image while maintaining low exposure to harmful radiation. It is also portable and retrofittable, capable of simultaneously capturing dual energy images and very high detective quantum efficiency (DQE) digital radiography images.
 

SCC helped the company navigate the complexities of standards creation – everything from providing advice on standards development strategies to planning and stakeholder engagement throughout the process. With SCC’s support, the company has led this work from the initial proposal throughout the development of the International Electrotechnical Commission (IEC) Standard applicable to their innovative product (IEC 62220-2-1 ED1 Medical electrical equipment – Characteristics of digital X-ray imaging devices – Part 2-1: Determination of dual-energy subtraction efficiency – Detectors used for dual-energy radiographic imaging).
 

As a relatively small and young company, KA Imaging has also taken a proactive approach to standardization, integrating it into the product development process. This standards development leadership has helped to increase visibility for their technology and accelerate product adoption.